Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases

Current medications for neurodegenerative and neuropsychiatric diseases such as Alzheimer's disease (AD), Huntington's disease (HD), Parkinson's disease (PD), and Schizophrenia mainly target disease symptoms. Thus, there is an urgent need to develop novel therapeutics that can delay,...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Bindu D., Snyder, Solomon H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920251/
https://www.ncbi.nlm.nih.gov/pubmed/31920936
http://dx.doi.org/10.3389/fneur.2019.01315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920251/
https://www.ncbi.nlm.nih.gov/pubmed/31920936
http://dx.doi.org/10.3389/fneur.2019.01315

Ejemplares similares